Contact
Please use this form to send email to PR contact of this press release:
Navrogen Establishes Research Collaboration with The National Cancer Institute to Test Mesothelin-Targeting Therapies
TO:
Steven Kyriakos
Navrogen, Incorporated
+1 6103992718